Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study

This publication has 42 references indexed in Scilit:

• Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
  Genetics in Medicine, 2016
• Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis
  The Lancet Oncology, 2015
• Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
  Genetics in Medicine, 2015
• Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel
  Cancer, 2014
• PALB2 mutations in male breast cancer: a population-based study in Central Italy
  Breast Cancer Research and Treatment, 2010
• CHEK2 1100delC and male breast cancer in the Netherlands
  Breast Cancer Research and Treatment, 2008
• Association between the BRCA2N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy
  BMC Cancer, 2007
• BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
  Breast Cancer Research and Treatment, 2007
• The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy
  Human Mutation, 2004
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
  Nature Genetics, 2002